These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22675782)

  • 41. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(216):56332-3. PubMed ID: 12358038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. International Conference on Harmonisation; Guidance on E2F Development Safety Update Report; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Aug; 76(163):52667-8. PubMed ID: 21894658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Jan; 63(10):2396-404. PubMed ID: 12296373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Particulate Contamination: Subvisible Particles General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jan; 74(6):909-10. PubMed ID: 20336864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2000 Dec; 65(251):83041-63. PubMed ID: 12356095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(225):65717-8. PubMed ID: 14631936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1999 Aug; 64(159):44928-35. PubMed ID: 12356094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(34):9948-9. PubMed ID: 22379685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 13 on Bulk Density and Tapped Density of Powders General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2013 May; 78(102):31944-5. PubMed ID: 23724425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 14 on Bacterial Endotoxins Test General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2013 Oct; 78(205):63221-2. PubMed ID: 24156134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 10 on Polyacrylamide Gel Electrophoresis General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Apr; 75(69):18509-10. PubMed ID: 20387318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(111):32358-9. PubMed ID: 15188781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. International Conference on Harmonisation; Guidance on E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Aug; 76(155):49773-4. PubMed ID: 21834216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(68):19074-6. PubMed ID: 18677821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Jun; 70(125):37861-2. PubMed ID: 15988855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International Conference on Harmonisation; E2B(R3) Electronic Transmission of Individual Case Safety Reports; Data Elements and Message Specification; Appendix on Backwards and Forwards Compatibility; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Feb; 79(35):9908-9. PubMed ID: 24611208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International Conference on Harmonisation; final recommendation for the revision of the permitted daily exposure for the solvent cumene according to the maintenance procedures for the guidance Q3C Impurities: Residual Solvents; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(36):10754-5. PubMed ID: 22379689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.